Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Category: News

News

Dr. Zanos has been recognized among world’s top 2% of scientists in the 2024 Stanford University database

No Comments
| News

We are pleased to announce that Dr. Zanos, Director of the Translational Neuropharmacology Lab, has been included in the Stanford University database of the world’s top 2% scientists, published by Elsevier. This prestigious recognition places Dr. Zanos among an elite group of researchers globally and reflects the significant impact of our laboratory’s research contributions to […]

Read More »

Zanos Lab research featured in the Cypriot “Politis” Newspaper

No Comments
| News

Our Master’s student and registered pharmacist, Georgios Kousathanas, was recently featured in the Cypriot “Politis” newspaper discussing one of our research topics on ketamine as an antidepressant treatment. The article, titled “Ketamine as a Model Drug for Rapid Antidepressant Action”, covers a part of the work being conducted in our laboratory on ketamine’s rapid-acting therapeutic […]

Read More »

Dr. Eleftheria Charalambous presents novel research findings on microbiome and brain health

No Comments
| News

We’re happy to share that our postdoctoral researcher Dr. Eleftheria Charalambous recently presented her latest findings at the World Federation of Societies of Biological Psychiatry (WFSBP) 2025 Congress. Her innovative research focuses on gut microbiome-wide association studies that identify specific viruses linked to mental health and brain aging. Dr. Charalambous’s work represents a significant advancement […]

Read More »

Our lab members were selected and participated in a leadership training workshop through European COST actions

No Comments
| News

We are pleased to announce that Drs. Zanos and Apostolakis from the Translational Neuropharmacology Lab have been successfully selected and completed the “COST Academy – Leadership training workshop” for early-career investigators. This specialized training workshop was designed for young researchers to develop leadership skills for positions within COST consortia and broader research environments. Our laboratory’s […]

Read More »

Infrastructure grant awarded to the Zanos Lab: TRACER Research Center

No Comments
| News

The Zanos Lab is proud to announce the award of €500,000 from the Research Promotion Foundation of Cyprus to establish the Translational Neuroscience and Behavioural Pharmacology Research Center (TRACER). This infrastructure grant will establish Cyprus’s first comprehensive neuropharmacology and systems neuroscience research facility, positioning our laboratory and the University of Cyprus at the forefront of […]

Read More »

Dr. Andria Michael brings Neuroimmunology to young minds

No Comments
| News

We’re excited to share that our postdoctoral researcher Dr. Andria Michael has authored an insightful article in Neolaia, Cyprus’s youth newspaper, explaining the fascinating connection between the immune system, neuroscience and depression. In her piece titled “How Does the Immune System Connect with Depression?”, Dr. Michael breaks down complex neurobiological concepts for young readers, exploring […]

Read More »

Exploring Misophonia via identifying innovative biomarkers

No Comments
| News

Our Ph.D. student, Ms. Despina Melanthiou presented her research project on identifying novel biomarkers for misophonia. Her work, that is being conducted at the University of Cyprus, explores the use of electroencephalography (EEG), heart rate variability (HRV), and other neuropsychophysiological markers, alongside biological markers from blood samples, to better understand this complex sensory processing disorder. […]

Read More »

New preprint: Transcriptomic insights into (2R,6R)-hydroxynorketamine’s possible therapeutic effects for Opioid Use Disorder

No Comments
| News

We are excited to share our latest research led by Dr. Anna Onisiforou with contributions from Dr. Andria Michael and Mr. Morfeas Koumas now available as a preprint on bioRxiv, titled “Transcriptomic mapping of the ventral hippocampus reveals (2R,6R)-hydroxynorketamine as a potential therapeutic agent for opioid abstinence.” This study investigates the therapeutic potential of (2R,6R)-hydroxynorketamine (HNK), a […]

Read More »

Dr. Apostolakis Shares Specialized Research Insights on Nicotine Addiction at European Psychology Congress Workshop

No Comments
| News

The Translational Neuropharmacology Lab is proud to announce that Dr. Apostolakis delivered a compelling presentation at the 19th European Congress of Psychology, held July 1-4, 2025, in Paphos, Cyprus. His research presentation, “Stress biomarkers and emotion regulation difficulties as predictive factors of vulnerability to nicotine addiction relapse,” highlighted groundbreaking findings in the field of smoking […]

Read More »

Dr. Zanos receives the 2025 Research Excellence Award from the University of Cyprus

No Comments
| News

We are excited to announce that Dr. Zanos, the Director of the Translational Neuropharmacology Laboratory, has been honored with the prestigious 2025 Research Excellence Award from the University of Cyprus. The award, presented by the Minister of Education of Cyprus on June 25, 2025, recognizes Dr. Zanos’ and our lab’s groundbreaking contributions to neuroscience and […]

Read More »

Posts pagination

Previous 1 … 3 4 5 … 13 Next

Recent Posts

  • Dr. Charalambous presents brain aging research at AAIC 2026 July 13, 2026
  • Dr. Panoutsopoulos presents research on ketamine and early neurodevelopment at FENS Forum 2026 July 8, 2026
  • Research spotlight: Unraveling the role of Eukaryotic Elongation Factor 2 Kinase in the antidepressant mechanism of (2R,6R)-hydroxynorketamine June 4, 2026
  • Research spotlight: Alexithymia and emotion regulation across smoking status groups May 26, 2026
  • New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease? March 12, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress